Competition Programme.

RIO-Europe compared rimonabant 5 mg/day and rimonabant 20 mg/day with medicine over a discourse stop of 2 days. All patients were asked to reduce their daily diet by 600 kcal/day. A aggregate of 1507 overweight/obese male or individual patients with body mass exponent [acomplia] >/= 30 kg/m2 (or BMI > 27 kg/m2 if comorbidity such as dyslipidemia or hypertension was present) were enrolled at 60 centers across Europe and the United States. All patients had stable artifact (variation <>/= 18 old age and none had type 1 or type 2 diabetes. The examination settlement was 96% Patrick White, 80% male, and had a mean age of 45 long time, mean BMI 36.5 kg/m2, mean weight unit 102 kg, and mean region mete 110 cm.